ExAblate Pallidotomy for Medically-Refractory Dyskinesia Symptoms or Motor Fluctuations of Advanced Parkinson's Disease

NAActive, not recruitingINTERVENTIONAL
Enrollment

92

Participants

Timeline

Start Date

February 9, 2018

Primary Completion Date

January 31, 2025

Study Completion Date

January 31, 2025

Conditions
Parkinson Disease
Interventions
DEVICE

ExAblate Pallidotomy

ExAblate Pallidotomy for Parkinson's Disease

DEVICE

Sham ExAblate Pallidotomy

ExAblate MRgFUS Sham Procedure

Trial Locations (20)

10016

New York University Health Langone, New York

10065

Weill Cornell Medicine, New York

19106

Pennsylvania Hospital Department of Neurosurgery, Philadelphia

20133

Fondazione IRCCS Neurological Institute Carlo Besta, Milan

21201

University of Maryland Medical System, Baltimore

22908

University of Virginia Health System, Charlottesville

28938

CINAC-Hospital HM Puerta del Sur, Móstoles

31008

Clinica Universidad De Navarra, Pamplona

33472

Palm Beach Neuroscience Institute/Sperling Medical Group, Boynton Beach

37134

Azienda Ospedaliera Universitaria di Verona, Univerista di Verona, Verona

43210

The Ohio State Wexner Medical Center, Columbus

55905

Mayo Clinic, Rochester

94305

Stanford University Medical Center, Stanford

98122

Swedish Medical Center, Seattle

3109601

Rambam Health Care, Haifa

02115

Brigham and Women's Hospital, Boston

M5T 2S8

Toronto Western Hospital, Toronto

Unknown

Severance Hospital, Yonsei University Health System, Seoul

Chang Bing Show Chwan Memorial Hospital, Changhua

St. Mary's Hospital, London

Sponsors

Lead Sponsor

All Listed Sponsors
lead

InSightec

INDUSTRY

NCT03319485 - ExAblate Pallidotomy for Medically-Refractory Dyskinesia Symptoms or Motor Fluctuations of Advanced Parkinson's Disease | Biotech Hunter | Biotech Hunter